Ledeberg, Belgium

Jennyfer Bultinck

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jennyfer Bultinck

Introduction

Jennyfer Bultinck, a distinguished inventor based in Ledeberg, Belgium, has made significant strides in the field of biotechnology. With a portfolio of 8 patents, she has dedicated her work to advancing medical treatments through innovative solutions. Her research focuses on modifying cytokines of the TNF superfamily, thereby providing new therapeutic options for various diseases.

Latest Patents

Among her most recent innovations is a groundbreaking patent titled "Targeted modified TNF family members." This invention introduces a modified cytokine from the TNF superfamily, engineered to exhibit reduced activity towards its receptor. The modification allows for specific delivery to target cells, enhancing treatment efficacy. The cytokine is designed as a single chain variant, enabling mutations that lead to low receptor affinity. The targeting mechanism involves the fusion of the modified cytokine with an antibody or antibody-like molecule, paving the way for potentially transformative treatments for diseases.

Career Highlights

Jennyfer Bultinck has contributed her talents to prominent organizations such as Vib Vzw and Ghent University. Her work within these institutions has been crucial in advancing research and innovation in her field. With her extensive knowledge and expertise, she continues to push the boundaries of what is possible in biotechnology.

Collaborations

Throughout her career, Jennyfer has collaborated with notable individuals like Jan Tavernier and Gilles Uze. These partnerships have fostered a creative environment that enhances the development of her innovative ideas. Working alongside esteemed colleagues has undoubtedly shaped the trajectory of her research and inventions.

Conclusion

Jennyfer Bultinck exemplifies a leading figure in the realm of biotechnology innovation. Her patented work on modified TNF family members is a testament to her commitment to improving health care through advanced scientific research. With continued efforts in her career, Bultinck is poised to make even greater contributions to the field, inspiring future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…